Systemic Treatment for Brain Metastases in NSCLC: A New Chapter

被引:0
|
作者
Acker, Fabian [1 ]
Althoff, Friederike C. [1 ]
Sebastian, Martin [1 ,2 ,3 ,4 ,5 ]
机构
[1] Univ Hosp Frankfurt, Dept Med 2, Hematol Oncol, Frankfurt, Germany
[2] German Canc Consortium DKTK, Partner Site Frankfurt Mainz, Mainz, Germany
[3] German Canc Res Ctr, Heidelberg, Germany
[4] Goethe Univ Frankfurt, Frankfurt Canc Inst, Frankfurt, Germany
[5] Univ Hosp Frankfurt, Dept Med 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany
关键词
NIVOLUMAB PLUS IPILIMUMAB; CELL LUNG-CANCER; PLATINUM-BASED CHEMOTHERAPY; PHASE-III TRIAL; POOLED ANALYSIS; 5-YEAR UPDATE; OPEN-LABEL; FOLLOW-UP; PEMBROLIZUMAB; OUTCOMES;
D O I
10.1016/j.jtho.2023.03.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:678 / 681
页数:4
相关论文
共 50 条
  • [1] Timing of stereotactic radiosurgery within systemic treatment in NSCLC brain metastases
    Bodensohn, Raphael
    Kolorz, Anna
    Reis, Jonas
    Werner, Simone
    Forbrig, Robert
    Garny, Sylvia
    Taugner, Julian
    De Colle, Chiara
    Belka, Claus
    Manapov, Farkhad
    von Baumgarte, Louisa
    Niyazi, Maximilian
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S812 - S814
  • [2] The treatment of NSCLC brain metastases
    Noel-Savina, E.
    Descourt, R.
    Le Fur, E.
    Robinet, G.
    ONCOLOGIE, 2012, 14 (05) : 305 - 309
  • [3] Brain metastases: new systemic treatment approaches
    Steindl, Ariane
    Berghoff, Anna Sophie
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2021, 14 (02) : 198 - 203
  • [4] Brain metastases: new systemic treatment approaches
    Ariane Steindl
    Anna Sophie Berghoff
    memo - Magazine of European Medical Oncology, 2021, 14 : 198 - 203
  • [5] Systemic Treatment of Brain Metastases
    Waqar, Saiama N.
    Morgensztern, Daniel
    Govindan, Ramaswamy
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (01) : 157 - +
  • [6] Publisher Correction: Brain metastases: new systemic treatment approaches
    Ariane Steindl
    Anna Sophie Berghoff
    memo - Magazine of European Medical Oncology, 2022, 15 (3) : 253 - 253
  • [7] Chemotherapy in the treatment of NSCLC and brain metastases.
    Baekke, J
    Sindrup, H
    Olesen, R
    Palshof, T
    Rytter, C
    Hansen, O
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 645S - 645S
  • [8] Targeting Angiogenesis for Treatment of NSCLC Brain Metastases
    Schettino, C.
    Bareschino, M. A.
    Rossi, A.
    Maione, P.
    Sacco, P. C.
    Colantuoni, G.
    Rossi, E.
    Gridelli, C.
    CURRENT CANCER DRUG TARGETS, 2012, 12 (03) : 289 - 299
  • [9] ERLOTINIB TREATMENT IN A PATIENT WITH BRAIN METASTASES BY NSCLC
    Montrone, M.
    Perrucci, B.
    Lotesoriere, C.
    Bruno, M.
    Fanelli, F.
    Pisconti, S.
    CANCER TREATMENT REVIEWS, 2010, 36 : S110 - S111
  • [10] Systemic Immunotherapy for the Treatment of Brain Metastases
    Cohen, Justine V.
    Kluger, Harriet M.
    FRONTIERS IN ONCOLOGY, 2016, 6